Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Ann Intern Med ; 159(10): 719, 2013 Nov 19.
Article in English | MEDLINE | ID: mdl-24247683
2.
J Alzheimers Dis ; 72(s1): S11-S35, 2019.
Article in English | MEDLINE | ID: mdl-31104030

ABSTRACT

The purpose of the 'First Regional Healthy Aging and Dementia Research Symposium' was to discuss the latest research in healthy aging and dementia research, public health trends related to neurodegenerative diseases of aging, and community-based programs and research studying health, nutrition, and cognition. This symposium was organized by the Garrison Institute on Aging (GIA) of the Texas Tech University Health Sciences Center (TTUHSC), and was held in Lubbock, Texas, October 24-25, 2018. The Symposium joined experts from educational and research institutions across the United States. The two-day Symposium included all GIA staff and researchers. Students, postdoctoral fellows, and faculty members involved in dementia research presented at the Symposium. Healthcare professionals, from geriatricians to social workers working with patients with neurodegenerative diseases, also presented. In addition, experts traveled from across the United States to participate. This event was comprised of multiple sessions, each with several oral presentations, followed by questions and answers, and discussion.


Subject(s)
Biomedical Research/trends , Congresses as Topic/trends , Dementia/epidemiology , Dementia/psychology , Healthy Aging/physiology , Healthy Aging/psychology , Biomedical Research/methods , Humans , Texas/epidemiology
3.
Am J Cardiol ; 102(6): 689-92, 2008 Sep 15.
Article in English | MEDLINE | ID: mdl-18773989

ABSTRACT

The metabolic syndrome (MS) is a constellation of risk factors associated with diabetes and cardiovascular disease. This syndrome consists of at least 3 parameters assessing central obesity, hypertension, high-density lipoprotein cholesterol, triglycerides, and impaired glucose metabolism. Whether persons with 4 or 5 risk factors are at higher risk than those with 3 risk factors is unclear. Also unclear is whether those without the MS but with 1 or 2 risk factors warrant therapy. We assessed cardiovascular and all-cause mortality as a function of the number of these risk factors. We followed 30,365 men for a median follow-up of 13.6 years. During follow-up, 1,449 participants died, 527 from cardiovascular causes. All of the individual parameters defining the MS were significantly associated with both all-cause and cardiovascular mortality (p <0.001). After adjustment for age and the other MS variables, hypertension was the most potent risk factor whereas central obesity and hypertriglyceridemia remained associated with both all-cause and cardiovascular mortality. A highly significant trend was also noted between both all-cause or cardiovascular mortality and the number of risk factors (p <0.001 for trend). Risk increased incrementally, beginning at 1 risk factor for cardiovascular mortality and at 2 risk factors for all-cause mortality. In conclusion, there is a continuum of risk as the number of metabolic syndrome risk factors increases. These findings add to the growing evidence that central obesity can independently and adversely affect health.


Subject(s)
Cardiovascular Diseases/mortality , Metabolic Syndrome/epidemiology , Adult , Blood Glucose/analysis , Cholesterol, HDL/blood , Humans , Hypertension/epidemiology , Hypertriglyceridemia/epidemiology , Longitudinal Studies , Male , Middle Aged , Obesity/epidemiology , Risk Assessment , Risk Factors
4.
Med Sci Sports Exerc ; 36(12): 2088-92, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15570144

ABSTRACT

BACKGROUND: Prospective study examining the relationship between cardiorespiratory fitness level and incidence of medical treatments during a 1-yr period before each of two examinations. A subset was also evaluated to assess whether improvement in fitness affected incidence of treatments. METHODS AND RESULTS: Part I: Six thousand six hundred seventy-nine healthy male subjects underwent medical examinations on two occasions, including a maximal exercise test. Division of subjects by fitness into quartiles (Q1 = low fitness through Q4 = high fitness) revealed an inverse relationship between fitness and outcome measures. Men in the low-fitness group had more office visits and overnight hospital stays than men in the high-fitness group (3.5% (Q1) vs 1.6% (Q4) men had 10+ office visits, and 10% (Q1) vs 5.0% (Q4) men had overnight hospital stays, P < 0.0001). These differences held after adjustment for potential confounding variables (age, follow-up yr, blood pressure, cholesterol, and smoking). Part II: Subjects in this subset (N = 2974) were evaluated to compare overnight hospital stays between low-fit men who remained low fit at the second examination, and low-fit men who became fit by the second examination. This cohort was divided into fitness tertiles (T1 = low fitness through T3 = high fitness). Those who improved their fitness by the time of the second examination had a decreased number of overnight hospital stays, compared with those who remained unfit at the time of the second examination (10.2% (T1 at second visit) vs 5.9% (T3 at second visit) had overnight hospital stays, P < 0.03). CONCLUSIONS: Men who maintain or become fit are less likely to have physician visits or overnight hospital stays, compared with men who are unfit.


Subject(s)
Health Services/statistics & numerical data , Health Status , Physical Fitness , Adult , Cohort Studies , Exercise Test , Hospitalization/statistics & numerical data , Humans , Male , Middle Aged , Prospective Studies
5.
Nutrition ; 18(9): 738-42, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12297209

ABSTRACT

OBJECTIVES: Multivitamin supplements are often sold to consumers with the claim that supplements modify risk factors associated with disease. Because few products are validated scientifically, we examined the effects of a 24-ingredient multivitamin formula in an open-label pilot investigation. METHODS: We examined 150 subjects for specific endpoints including blood concentrations of selected vitamins, homocysteine, lipids, and low-density lipoprotein (LDL) oxidation indices at baseline and at 12 and 24 wk. RESULTS: One hundred forty-one subjects were successfully assayed for and showed significant time effects for homocysteine and vitamin B6 (as pyridoxal-5'-phosphate), B12, and folic acid concentrations during treatment (P < 0.0001). Vitamin B6, B12, and folic acid concentrations were significantly elevated at weeks 12 and 24 (P < 0.05). Homocysteine concentration decreased significantly during the same periods (7.9 +/- 2.4 versus 6.7 +/- 1.7 versus 6.7 +/- 1.9 mM/mL; P < 0.05). There were correlations relating homocysteine to vitamins B6 (P = 0.001, r(2) = 0.03), B12 (P < 0.001, r(2) = 0.09), and folic acid (P = 0.001, r(2) = 0.10). Significant time effects were noted for 121 subjects successfully assayed for vitamin C, E, beta-carotene, LDL oxidation rate, and LDL lag time (P < 0.0001). Post hoc assessment showed elevations in vitamin C, E, and beta-carotene concentrations at 12 and 24 wk (P < 0.05). LDL oxidation lag time at baseline (57.5 +/- 13.9 min) increased by 12 wk (63.5 +/- 19.0 min; P < 0.05) and 24 wk (63.8 +/- 16.3 min; P < 0.05). LDL oxidation rate at baseline (9.7 +/- 3.0 microM x min(-1). g(-1)) was reduced at 12 wk (7.1 +/- 2.5 microM x min(-1) x g(-1); P < 0.05) and 24 wk (6.0 +/- 2.0 microM x min(-1) x g(-1); P < 0.05). Only vitamin C was significantly correlated with LDL oxidation rate (P = 0.05, r(2) = 0.003). CONCLUSIONS: A multi-ingredient vitamin formula with antioxidant properties has measurable effects on homocysteine and LDL oxidation indices.


Subject(s)
Antioxidants/administration & dosage , Homocysteine/blood , Lipid Peroxidation , Lipoproteins, LDL/metabolism , Vitamins/administration & dosage , Vitamins/blood , Adult , Aged , Antioxidants/analysis , Ascorbic Acid/administration & dosage , Ascorbic Acid/blood , Cohort Studies , Dietary Supplements , Female , Folic Acid/administration & dosage , Folic Acid/blood , Humans , Male , Middle Aged , Oxidation-Reduction , Pilot Projects , Pyridoxal Phosphate/blood , Pyridoxine/administration & dosage , Vitamin B 12/administration & dosage , Vitamin B 12/blood , Vitamin E/administration & dosage , Vitamin E/blood , beta Carotene/administration & dosage , beta Carotene/blood
SELECTION OF CITATIONS
SEARCH DETAIL